Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

MRC Uganda Publications

Browse a collection of academic publications and research papers, contributed to by personnel from the Unit.

RICK activates a NF-kappaB-dependent anti-human cytomegalovirus response.
Eickhoff, J; Hanke, M; Stein-Gerlach, M; Kiang, TP; Herzberger, K; Habenberger, P; Müller, S; Klebl, B; Marschall, M; Stamminger, T; COTTEN, M;
2003
The Journal of biological chemistry, (2003).279 10 10.1074/jbc.m312893200.
Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein.
Daub, H; Blencke, S; Habenberger, P; Kurtenbach, A; Dennenmoser, J; Wissing, J; Ullrich, A; COTTEN, M;
2002
Journal of virology, (2002).76 16 10.1128/jvi.76.16.8124-8137.2002.
The epidemiology of conjunctival squamous cell carcinoma in Uganda.
NEWTON, R; Ziegler, J; Ateenyi-Agaba, C; Bousarghin, L; Casabonne, D; Beral, V; Mbidde, E; Carpenter, L; Reeves, G; Parkin, DM; Wabinga, H; Mbulaiteye, S; Jaffe, H; Bourboulia, D; Boshoff, C; Touzé, A; Coursaget, P; Uganda Kaposi's Sarcoma Study Group,;
2002
British journal of cancer, (2002).87 3 10.1038/sj.bjc.6600451.
Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda.
Rutakingirwa, M; Ziegler, JL; NEWTON, R; Freers, J;
2002
Tropical medicine & international health : TM & IH, (2002).4 3 10.1046/j.1365-3156.1999.43376.x.
HIV in Africa (Communication arising): chemokine-receptor genes and AIDS risk.
Ramaley, PA; FRENCH, N; KALEEBU, P; Gilks, C; WHITWORTH, J; Hill, AV S;
2002
Nature, (2002).417 6885 10.1038/417140a.
Histone deacetylase 1 inactivation by an adenovirus early gene product.
Chiocca, S; Kurtev, V; Colombo, R; Boggio, R; Sciurpi, MT; Brosch, G; Seiser, C; Draetta, GF; COTTEN, M;
2002
Current biology : CB, (2002).12 7 10.1016/s0960-9822(02)00720-0.
Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.
KALEEBU, P; FRENCH, N; Mahe, C; Yirrell, D; Watera, C; Lyagoba, F; Nakiyingi, J; Rutebemberwa, A; Morgan, D; Weber, J; Gilks, C; WHITWORTH, J;
2002
The Journal of infectious diseases, (2002).185 9 10.1086/340130.
Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda.
Lugada, ES; Watera, C; Nakiyingi, J; ELLIOTT, A; Brink, A; Nanyunja, M; FRENCH, N; Antivelink, L; Gilks, C; WHITWORTH, J;
2002
The international journal of tuberculosis and lung disease, (2002).6 4
Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000.
Osmanov, S; Pattou, C; Walker, N; Schwardländer, B; Esparza, J; WHO-UNAIDS Network for HIV Isolation and Character,;
2002
Journal of acquired immune deficiency syndromes (1999), (2002).29 2 10.1097/00042560-200202010-00013.
First trial of the HIV-1 vaccine in Africa: Ugandan experience.
Mugerwa, RD; KALEEBU, P; Mugyenyi, P; Katongole-Mbidde, E; Hom, DL; Byaruhanga, R; Salata, RA; Ellner, JJ; HIV-1 Vaccine Trial Group,;
2002
BMJ (Clinical research ed.), (2002).324 7331 10.1136/bmj.324.7331.226.